Eli Lilly has been hit with a subpoena from the New York Attorney General’s Office over the pricing and sales of its insulin products, the drugmaker disclosed in a filing.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,